Open access peer-reviewed chapter

Correlations between Ultrasound and Pathology in Fetal Ventricular System Anomalies

Written By

Tanya Kitova, Borislav Kitov, Denis Milkov and Aida Masmoudi

Submitted: 23 May 2017 Reviewed: 25 October 2017 Published: 20 December 2017

DOI: 10.5772/intechopen.71934

From the Edited Volume

Congenital Anomalies

Edited by Stefania Tudorache

Chapter metrics overview

1,212 Chapter Downloads

View Full Metrics


A total of 113 cases of fetal hydrocephalus with a lethal outcome (FHLO) from the Embryo-Fetopathologic Clinic at the Center for Maternity and Neonatology, Tunis, Tunisia and Obstetrics and Gynecology Clinic at St. George EAD University Hospital, Plovdiv, Bulgaria were studied, 86 of which had syndrome malformations: neural tube defects (NTDs)—29.2%, chromosomal abnormalities—23.9%, skeletal dysplasias—9.8%, VACTERL association—5.3%, Dandy-Walker malformation—3.4%, Other—14.2%. Risk factors for FHLO are miscarriages (odds ratio (OR): 19.500; confidence interval (CI): 4.020-94.594), stillbirths (OR: 10.897; CI: 1.169-10.564) and previous birth of a malformative child (OR = 5.385; CI: 1.385–18.896). FHLO is significantly associated with a maternal age over 40 years and third degree consanguinity of the fetus (OR = 18.500; CI: 1.146–298.547). The trisomies in our study were 27 (23.9%) and are significantly associated with an age above 38 years and FHLO (OR = 13.689; CI: 3.952–52.122). In medical abortion, stillbirth, or neonatal death, a fetopathological study enriches our knowledge of malformations, complements and completes the ultrasound examination, modifies genetic counseling, and determines the medical behavior in subsequent pregnancies. Also, associated risk factors and fetopathological changes in FHLO must be studied to increase the ultrasound prenatal diagnosis success.


  • congenital hydrocephalus
  • ultrasound
  • MRI
  • cerebral anomalies
  • risk factors

1. Introduction

Congenital hydrocephalus (CH) is a severe malformation which is often associated with other abnormalities. The prenatally diagnosed serious birth defects, especially those associated with a high risk of premature death, stillbirth, or neonatal death, are often referred to as “lethal,” as it is assumed that their potential treatment will be unsuccessful, which is the basis for the decision for the interruption of pregnancy due to medical reasons [1, 2]. Depending on the clinical criteria used in the definition of the disease, its incidence varies from 1 to 32 per 10,000 live births [3]. An increase in the prenatal diagnosis of CH has been observed, whereas the incidence of stillbirths remains stable. The interruption of pregnancy due to medical reasons reduces by almost a half the rate of hydrocephalus in live births. Currently, prenatal ultrasound is able to visualize ventriculomegaly, which can be caused by a number of reasons. Knowledge of the risk factors associated with CH may increase the chances of an early prenatal ultrasound diagnosis. Animal experiments have found that a wide range of environmental factors can cause hydrocephalus. They include alcohol consumption, X-rays, infections, eating disorders, and exposure to chemicals during pregnancy [4]. It has been established that one gene (L1 of Xq28 encoded for L1CAM) is connected with CH in humans. Although X-linked CH has a frequency of about 2–7% of all cases, L1CAM is found in about 15% of sporadic cases [5]. L1CAM mutations are closely related to stenosis of the cerebral aqueduct, the major pathology causing hydrocephalus in these cases. Sipek et al., in their study of CH for the period 1961–2000 in the Czech Republic, found that a mother’s age of over 37 years was statistically significantly related to CH, unlike the study by Van Landingham et al. [4, 6].


2. Aim of the study

To study the prenatally ultrasound diagnosed ventriculomegaly by fetopathological autopsy in fetuses, which ended in interruption of pregnancy due to medical reasons, stillbirth, or neonatal death, by searching associated with the congenital hydrocephalus isolated or syndromic malformations as well as the eventual risk factors for their occurrence.


3. Materials and methods

A total of 113 fetuses with CH were studied whose outcome was lethal. One hundred and three of them were received over a period of 3 years (2006–2009) and autopsied at the Embryo-Fetopathologic Clinic at the Center for Maternity and Neonatology, Tunis, Tunisia, out of a total of 21,316 births. Ten of the cases were from the Obstetrics and Gynecology Clinic at St. George EAD University Hospital, Plovdiv, Bulgaria, during the year 2016 out of a total of 2104 deliveries. The incidence of fetal hydrocephalus with a lethal outcome (FHLO) in both centers is almost identical—4.8 and 4.9 per 1000 births.

The fetuses are the result of interruption of pregnancy due to medical reasons, spontaneous abortions, and stillbirths. The maternal and fetal data were collected from the obstetric history, and a classical autopsy was performed immediately following the expulsion of the fetus, after authorization for macroscopic and microscopic examination. The autopsy includes observation, biometry of the fetus, and in situ examination of the body cavities. The examination of the brain was performed 6 months later, after conservation with 10% formalin. It began with biometrics, measurement of the biparietal and frontal-occipital diameters, and study of the relationship between ocular distance and eyelid length. After opening the cranial cavity, the meninx, brainstem, cerebellum, cerebral hemispheres, gyrification, and morphology were observed. The biometry of the brain—weight and bitemporal and fronto-occipital diameters of the encephalon, and weight and transverse diameter of the cerebellum—was also studied. The ventricular system was examined by horizontal or vertical hemispheric slices until the central part of the lateral ventricle was opened. The presence, shape, and thickness of corpus callosum were examined. With a linear meter, the ventricular width in the central part was measured. At a width of more than 10 mm, ventricular dilatation was diagnosed as hydrocephalus and at a diameter of over 15 mm—major hydrocephalus. In each study, material was taken for histological examination of the cerebral cortex, cerebellum, brainstem, choroid plexus, and cerebral meninx. SPSS version 19 was used for the interpretation of the data. A descriptive analysis and χ2-analysis were used.


4. Results

  • Age structure of the mothers: The age range of mothers carrying fetuses with FHLO was 21–43 years. Under 26 years of age were 24 mothers (22%), 27–35 were 64 (58%) and 36–50 years of age were 21 mothers (19.3%). The average age of the mothers was 29.5 ± 0.72.

  • Number of previous pregnancies of the mothers: Most of the mothers carrying FHLO had one previous pregnancy (38.1%), followed by mothers with two previous pregnancies (19.5%). The average number of previous pregnancies is 2.50 ± 1.808, with a range of 1 to 5 pregnancies. There were no data for previous pregnancies for only 2.7% of the mothers.

  • Number of previous births of the mothers: In the studied group, most of the mothers had one previous birth (36.6%), followed by mothers without previous births (31.3%). The average number of births is 1.24 ± 1.23, with a range of 0–5.

  • Blood group of the mothers: Data were collected for the mothers’ blood groups, but unfortunately there is no information for about 21% of the mothers carrying a fetus with FHLO of the studied group. It is noteworthy that most of the mothers were of blood group O(+) – 36 (32.0%), followed by А(+) – 23 (over 20.0%).

  • Consanguinity: In our study, 27.4% of the marriages were consanguineous, with those of first degree being 15.4%, those of second degree 8.3%, and of third 3.7%.


5. Risk factors

In the present study, 80 of the pregnancies (70.7%) were without risk factors, and only 33 (29.3%) were under the influence of such. The risk factors were grouped into three categories: obstetric risk factors from past events, risk factors due to diseases of the mother, and exogenous risk factors.

  1. Obstetric risk factors. This group includes spontaneous abortions—13 (11.5%), voluntary abortions—1 (0.9%), birth of a child with malformations—11 (9.8%), stillbirths—2 (1.8%), multifetal pregnancy—2 (1.8%), and multi-year sterility—4 (3.5%).

  2. Endogenous risk factors. The risk factors from the mother include maternal age, hypertension—1 (0.9%), diabetes mellitus—2 (1.8%), bronchial asthma—2 (1.8%), thalassemia—2 (1.8%), and epilepsy—3 (2.7%).

  3. Exogenous risk factors. Exogenous risk factors for the pregnancy include pregnancies carried in geographical areas near mines and underground mineral water deposits and consanguineous marriages. In our study, the pregnancies from geographic regions with mining and underwater mineral water deposits were 5 (4.4%). Supplementation with folic acid is mandatory in Tunisia and Bulgaria. There were no women without folic acid supplementation.

The term of pregnancy termination is presented in Figure 1. Most interrupted pregnancies are between the 20th and 24th gestational weeks. Six pregnancies were carried to birth.

Figure 1.

Term of pregnancy termination.

Motives for pregnancy termination. Interruption of pregnancy due to medical reasons was performed in 87 cases (77%); spontaneous abortions were 13 (11.5%), and there was 1 voluntary abortion (0.9%). There were 2 live births (1.8%) and 2 stillbirths (1.8%). In eight of the cases (7%), there is no information on the motive for pregnancy interruption (Figure 2).

Figure 2.

Motives for pregnancy termination.


6. Anthropometric characteristics of the fetuses

Distribution of lethal hydrocephalus by gender (sex ratio). The genders were equally affected, but the mean weight of male fetuses (842.17 ± 115.2) was less than that of female fetuses (892.06 ± 101.1), without the difference being statistically significant (u = 0.51, p > 0.05).

Age of the fetus. The average pregnancy term in the entire study is 24 ± 0.45 gestational weeks. The fetal expulsion in two-thirds of the cases occurred before the 24th gestational week, with the smallest fetus being 13 gestational weeks (Figure 1).

Fetus weight. The average weight of the fetuses is 865.99 ± 809.8 g with a range of 23–3800 g. It is worth noting that 50 fetuses (44.2%) weigh less than the corresponding gestational age.


7. System anomalies of the fetus

The head, extremities, and respiratory system anomalies associated with FHLO are presented in Table 1.

SystemsTypes of anomaliesAnomaliesN/%
Lips, soft and hard palateCleftsCleft lip
Cleft palate
Labia palate cleft
Uvula cleft palate
ConfigurationsHigh palate25/22.1
Anomalies of the noseConfigurations
Snub nose
Choanal atresia
Head and limb abnormalitiesHead
Curved foot
Short limbs
Agenesia of finger
Finger clinodactyly
Anomalies of the respiratory systemHypoplasia
Incorrect lobulation
Hypoplasia and
Incorrect lobulation
Situs inversus
Liver agenesis


Table 1.

Hydrocephalus-related abnormalities of the head, extremities, and respiratory system.

The cardiovascular system abnormalities are a total of 32 and are from all groups. The digestive system abnormalities are 56 and are broken down into groups: mesenteric (affecting the small intestine and colon), parenchymal (affecting the liver and spleen), anal imperforation (affecting the terminal part of the intestines), gall bladder agenesis, and situs inversus. The parenchymal and mesenteric abnormalities are evenly distributed. The gender abnormalities are present in both male and female fetuses with a ratio of female to male of 8:7. Hermaphroditism was established in four (3.5%) fetuses. The fatal hydrocephalus-associated anomalies of the cardiovascular, digestive, excretory, and genital systems are presented in Table 2.

SystemsTypes of anomaliesAnomaliesN/%
Anomalies of the cardiovascular systemPosition
DefectsAtrial septal defect (ASD)
Ventricular septal defect (VSD)
Both together
Tetralogy of Fallot
Minor form of AV channel of the heart
AV channel of the heart
StenosesAortic valve stenosis
Pulmonary valve stenosis
TranspositionTransposition of the great vessels (TGV)1/0.9
IsomerismIsomerism of incoming vessels of the heart3/2.7
HypoplasiaHypoplastic right heart syndrome (HRHS)1/0.9
Digestive system abnormalitiesMesenterialCommon mesentery
Accessory spleen
ImperforationsImperforate anus8/7.1
AgenesisGallbladder Agenesis1/0.9
Situs inversus1/0.9
Anomalies of kidney and urinary tractKidneysPtosis of the kidney
Horseshoe kidney
Agenesis (uni- and bilateral)
Tubular necrosis
Cystic dysplasia
Urinary tractPelvicalyceal dilatation
Hypoplasia of bladder
Colovesical fistula
Agenesis of ureter
Anomalies of the genitalsFemaleBicornuate uterus
Ovarian hypoplasia Vaginal Atresia
Posterior urethral valve

Table 2.

Hydrocephalus-related abnormalities of cardiovascular, digestive, excretory, and genital systems.

Association of hydrocephalus with other brain abnormalities. In 85 fetuses (76%), hydrocephalus was associated with other brain abnormalities: polygyria—12 (10.7%); lissencephaly—2 (1.8%); agenesis of corpus callosum—18 (16%); agenesis of the cerebellar vermis—19 (16.9%); diastamatomyelia—1 (0.9%); stenosis of the Sylvian aqueduct—5 (4.4%); holoprosencephaly—1 (0.9%) and cyst of the choroid plexus—2 (1.8%) (Table 3, Figure 4). The relations between the prenatal and postnatal diagnosis of hydrocephalus-associated brain abnormalities are shown in Figure 3.

Brain associationsNumber of cases%
Agenesis of corpus callosum1815.9
Agenesis of cerebellar vermis1916.8
Cerebellar hypoplasia2522.1
Aqueductal stenosis (stenosis of the aqueduct of Sylvius)54.4
Choroid plexus cysts21.8

Table 3.

Distribution of associated brain abnormalities with lethal hydrocephalus.

Figure 3.

Relations between the prenatal and postnatal diagnosis of hydrocephalus-associated brain abnormalities. Abbreviations: CC, corpus callosum; CV, cerebeller vermis; H, hypoplasia.

Figure 4.

(A) Polygria (inferior view of the brain); (B) Agenesis of corpus callosum (medical view of hemisphere); (C) Extracted brain and spinal cord from the skull and vertebral canal. Split of the cord. Diastematomyelia; (D) Thorac-lumbar spina bifidia; (E) Occipital meningo-encephalocele; (F) Rachischisis; (G) Wedging of the cerebellar tonsils through the foramen magnum. Arnold-Chiari malformation; (H) Cystic dilatation of IVth ventricle, elevating of the tentorium, cerebellar hypoplasia. Dandy-Walker malformation; (I) Ventriculomegaly-ultrasound examination; (J) Ventriculomegaly (horizontal section of the right hemisphere); (K) Holoprosencephaly. Fetal MRI; (L) Holoprosencephaly. Fetal autopsy (White-black arrow—hemisphere, white arrow—brain stem, dotted arrow—cerebellum).

The hydrocephalus-associated syndromes and malformations are presented in Table 4.

Types of anomaliesAnomaliesN/%
Neural tube defectsSpina bifida
Chromosomal abnormalitiesTrisomy 21
Trisomy 18
Trisomy 13
Trisomy 15
Trisomy 7 + 2
Skeletal dysplasiasEllis-van Creveld syndrome
Thanatophoric dysplasia
Osteogenesis imperfecta
VACTERL association6/5.3
Dandy-Walker malformation4/3.4
Other syndromes and malformationDiGeorge syndrome
Meckel-Gruber syndrome
Fraser syndrome
Fryns syndrome
Arnold-Chiari malformation

Table 4.

Distribution of syndromes and malformations associated with lethal hydrocephalus.

Most are neural tube defects followed by trisomies and skeletal dysplasias. The VACTERL association has been established in six fetuses (5.3%), four of which were male and two female, and the Dandy-Walker malformation in four fetuses (3.5%) (Figure 4).

The Meckel-Gruber syndrome, which is a ciliopathy, was established six times (5.4%). A karyotype study was performed on 23 fetuses (20.5%)—one by fluorescent in situ hybridization (FISH) and the rest by chromosome study. A magnetic resonance tomography (MRI) was performed in three cases.

The degree of hydrocephalus according to the fetopathological study is major hydrocephalus (hydrancephaly; >15 mm)—15 cases (13.3%) and ventriculomegaly (>10 mm)—77 cases (69%). Obstructive hydrocephalus as a result of intraventricular hemorrhage was found in 20 fetuses (17.7%) (Table 5, Figure 4).

According to the degree of hydrocephalusNumber of cases%
Major hydrocephalus (hydranencephaly)1513.3%
Hydrocephaly due to intraventricular hemorrhage2017.7%

Table 5.

Distribution of data on the extent and origin of hydrocephalus.

The assessment of the significance of spontaneous abortions, abortions due to medical reasons, stillbirth, and a previous child with malformations as risk factors for the occurrence of hydrocephalus was accomplished by means of a χ2-analysis (Table 6).

IndicatorsGroupsWithout risk factorsRisk factorsTotalχ2Fisher
There are215.41184.613100.0(4.020–94.594)
There are211.81588.217100.0(6.817–154.954)
There are1204805100.0(1.169–10.564)
Baby with malformationNo7675.42625.5102100.06.9880.0085.385
There are436.4763.611100.0(1.385–18.896)

Table 6.

Risk factors and lethal hydrocephalus.

Abbreviations: No, number; CI, confidence intervals; OR, odds ratio; χ2, chi-square; P, sig.

The proportion of spontaneous abortion is almost four times higher, and the abortion due to medical reasons is more than four times higher, when compared to other risk factors for FHLO. Hydrocephalus is almost three times more likely to develop in cases of previous stillbirths in the obstetric history and more than two times more likely to occur in the presence of a pre-term birth of a child with a malformation, compared to the studied risk factors. The assessment of the significance of the different degrees of consanguinity in the presence of a child with malformations, epileptic mother, as well as the mother’s age is shown in Table 7.

IndicatorsGroupsNo malformationBaby with malformationTotalχ2Fisher
There are2777.1822.935100.0
IndicatorsGroupsWithout epilepsyEpilepsyTotalχ2РOR
Consanguinity first degreeNo7796.133.977100.025.7420.00024.667
There are750.0750.014100.0
IndicatorsGroupsWithout risk factorsRisk factorsTotalχ2РOR
Consanguinity second degreeNo7193.456.676100.04.0140.04575.680 (0.872–36.997)
There are571.4228.67100.0
Maternal ageOthers8195.344.785100.04.2470.0394.203 (0.977–18.601)
27–35 years1982.6417.423100.0
IndicatorsGroupsUnder 40 years of ageOver 40 yearsTotalχ2РOR
Consanguinity third degreeNo7497.422.676100.07.4470.00618.500
There are266.7133.33100.0

Table 7.

Consanguinity, risk factors, and lethal hydrocephalus.

Abbreviations: No, number; CI, confidence intervals; OR, odds ratio; χ2, chi-square; P, sig.

The incidence of FHLO is nearly six times higher when it is the result of a consanguineous marriage with a history of a previous pregnancy with a malformation, relative to the presence of hydrocephalus of a non-consanguineous marriage with no such a history. Almost 13 times higher is the incidence of FHLO in cases of maternal epilepsy with a consanguineous marriage of first degree (first cousins), when compared to the proportion of FHLO in a fetus carried by an epileptic mother but not from such a marriage. Over four times higher is the proportion of FHLO in cases of consanguinity of second degree, when compared to hydrocephalus influenced by the other studied maternal risk factors. Almost four times higher is the proportion of FHLO with a maternal age between 27 and 35 years compared to other ages, with maternal risk factors present. The rate of hydrocephalus when the maternal age is over 40 years and with consanguinity of third degree is 13 times greater than women over 40 years of age without the risk factor consanguinity. The assessment of the degree of risk of consanguinity, the presence of spontaneous abortion, and the mother’s blood group is presented in Table 8.

Indicators.GroupsAnother groupА+Totalχ2РOR
Consanguinity first degreeNo6381.81418.277100.04.2060.043.375
IndicatorsGroupsAnother groupO+Totalχ2РOR
There are646.2753.813(1.022–10.789)

Table 8.

Blood groups, risk factors, and lethal hydrocephalus.

Abbreviations: No, number; CI, confidence intervals; OR, odds ratio; χ2, chi-square; P, sig.

When the mother is from the A(+) blood group and has a consanguineous marriage (giving second-degree consanguinity in the fetus), FHLO has a two times higher incidence than in cases without consanguinity. Around two times higher is the incidence of FHLO, carried by mothers with O(+) blood group and a history of a previous spontaneous abortion, compared to the occurrence when there is no such history. The degree of significance of the mother’s age for the incidence of polygyria and abortions, obstetric and other risk factors, as well as the blood group for the occurrence of agenesis of the cerebellar vermis are shown in Table 9.

IndicatorsGroupsWithout polygyriaPolygyriaTotalχ2РOR
Maternal age≤358292.177.989100.04.8940.0274.894 (1.094–13.94)
IndicatorsGroupsWithout agenesis of cerebellar vermisAgenesis of cerebellar vermisTotalχ2РOR
There are1164.7635.317100.0
Obstetric risk factorsNo7187.71012.381100.04.4320.0352.905
There are2271.0929.031100.0(1.048–8.052)
Risk factorsNo4790.459.652100.03.8980.0463.463
There are1973.1726.926100.0(0.977–12.274)
А+ blood groupNo7886.71213.390100.03.8300.0502.844
There are1669.6730.423100.0(0.969–8.342)

Table 9.

Brain abnormalities, risk factors, and lethal hydrocephalus.

Abbreviations: No, number; CI, confidence intervals; OR, odds ratio; χ2, chi-square; P, sig.

The association of FHLO and polygyria is more than three times higher in cases where the mother is over 35 years of age, when compared to cases with a mother’s age less than 35 years. More than 2.5 times higher is the incidence of FHLO associated with agenesis of the cerebellar vermis in cases of a mother with a previous abortion, when compared to cases without a previous abortion. In the present study, the incidence of the association FHLO and agenesis of the cerebellar vermis is more than two times higher when exposed to the obstetric risk factors. Almost three times higher is the incidence of the association of FHLO and agenesis of the cerebellum in cases in which the mother’s blood group is A(+), when compared to other maternal blood groups. The assessment of the importance of the maternal age for the association of hydrocephalus with trisomies, as well as the mother’s blood group for the association of hydrocephalus and agenesis of corpus callosum is presented in Table 10.

IndicatorsGroupsWithout trisomyTrisomyTotalχ2РOR
Maternal age≤388890.799.397100.020.5180.00013.689
IndicatorsGroupsWithout agenesis of corpus callosumAgenesis of corpus callosumTotalχ2РOR
O+ blood groupNo5386.9813.161100.04.4410.0353.614
There are1164.7635.317100.0

Table 10.

Risk factors, trisomy, agenesis of corpus callosum, and lethal hydrocephalus.

Abbreviations: No, number; CI, confidence intervals; OR, odds ratio; χ2, chi-square; P, sig.

The rate of FTLO associated with trisomy is more than six times higher when the mother’s age is over 38 years of age, than in younger than 38-year-old mothers. Almost three times higher is the share of the association of FHLO with agenesis of corpus callosum in the fetus in cases of O(+) maternal blood group.


8. Discussion

Currently, prenatal ultrasound is able to visualize ventriculomegaly. Knowledge of the risk factors associated with CH may increase the success of the prenatal ultrasound study. It has been established that a wide range of factors can cause hydrocephalus in animal experiments including alcohol consumption [7], X-ray [8], infections, food disorders, exposure to chemicals [9] and medications taken during pregnancy [10].

Our study is similar to those of Fernell et al., Stoll et al., and Porto et al. which showed that CH was significantly associated with previous abortions, stillbirth, and birth of a child with a malformation [11, 12, 13]. Our findings show that the risk of FHLO is increased in cases of previous spontaneous abortions (odds ratio (OR) = 19.500, confidence interval (CI): 4.020–94.594), stillbirth (OR = 10.897; CI: 1.169–10.564), and births of a child with a malformation (OR = 5.385; CI: 1.385–18.896). Pregnancy complications, such as an increase in the amniotic fluid over 1500 ml (polyhydramnios) or a reduction below 500 ml (oligohydramnios), are also considered as potential risk factors for CH [12, 13].

The role of consanguinity is also known for the occurrence of congenital malformations such as hydrocephalus, postaxial polydactyly of the hands, and defects of the lips and palate [13, 14]. In our study, FHLO is significantly associated with a maternal age over 40 years and third-degree consanguinity of the fetus (OR = 18.500; CI: 1.146–298.547). FHLO, previous pregnancies with malformations, and consanguinity are also significantly associated (OR = 7.309; CI: 1.806–29.584). FHLO with agenesis of the cerebellar vermis is significantly associated with the effect of obstetric risk factors (OR = 2.905; CI: 1.048–8.052).

Almost all studies have documented a slightly higher percentage of male fetuses in cases of CH in live births and stillbirths as well as in fetopathologic autopsies [15, 16, 17, 18]. Van Landingham et al. did not find a difference in the genders of the children with hydrocephalus compared to the general population [4].

According to the study of Van Landingham et al. in 2009, the mother’s age is not associated with CH, unlike the study by Sipek et al. for the period 1961–2000 in the Czech Republic which found that a mother’s age over 37 years was significantly associated with CH [4, 6]. Hydrocephalus is significantly associated with a mother’s age above 40 years and third-degree consanguinity, and it is 18 times higher compared to women above 40 years of age without consanguinity (OR = 18.500; CI: 1.146–298.547).

In regard to maternal disease, it is known that mothers suffering from diabetes mellitus have a significantly higher risk for giving birth to a child with congenital malformations, especially cardiovascular and neural tube defects [4, 19, 20].

Hydrocephalus is often divided by genetic specialists into a syndromic and non-syndromic form, depending on the presence of associated malformations [21, 22]. Some authors prefer to differentiate hydrocephalus in which the phenotype is characterized mainly with brain malformations and hydrocephalus which is associated with significant physical anomalies and clinical symptoms [23]. In cases with a specific clinical syndrome or genetic changes, hydrocephalus is best to be defined as hydrocephalus associated with the corresponding syndrome.

Some enzyme mutations result in defective neuron connections with the extracellular matrix, abnormal formation of the limiting glial membrane, and disturbances in the neuronal migration [24, 25]. As a result, characteristic brain malformation develops—loss of cerebral gyrification, abnormal white matter of the hemispheres as well as brainstem anomalies (flat pons, enlarged tectum, and curved medulla oblongata), often associated with an aqueductal stenosis and cerebellar cysts. These findings often cannot be found by the prenatal examination, especially in cases of significant ventriculomegaly, making the MRI study essential [26]. In our study, the risk increases almost five times for the association of FHLO and polygyria when the mother’s age is above 35 years (OR = 4.894; CI: 1.094–13.94). The association of FHLO and agenesis of the cerebellar vermis is significantly associated with previous abortions (OR = 3.483; CI: 1.099–1.040) and the effect of risk factors (OR = 3.463; CI: 0.977–12.274). Ventriculomegaly is significantly associated with agenesis of corpus callosum, as well as O(+) blood group of the mother, when compared to other blood groups (OR = 3.614; CI: 1.044–12.510). Hydrocephalus may be associated with other brain malformations such as holoprosencephaly, rhombencephalosynapsis, Aicardi syndrome, agenesis of corpus callosum, and periventricular heterotopia [27, 28, 29, 30, 31].

Some cytogenetic malformations are associated with hydrocephalus, including trisomy 13, 18, 21, and triploidy [32]. The trisomies in our study were 27 (24.1%) and their occurrence is significantly associated with a mother’s age above 38 years (OR = 13.689; CI: 3.952–52.122).

NTD-associated hydrocephalus has a multifactor genesis. Experiments with animals have found that the intrauterine leak age of cerebrospinal fluid causes the Arnold-Chiari type II malformation, which causes an obstruction of the cerebrospinal fluid flow [33, 34]. Genetic mutations responsible for planar cell polarity such as Fuzzy (FUZ), VANGL1, and CELSR1 add to the development of NTDs [35, 36, 37]. Other mutations of genes with a relation to planar cell polarity (CELSR2 and MPDZ) may cause hydrocephalus regardless of the presence of NTDs [38, 39]. The specific pathogenetic mechanism is not completely clear, but it is accepted that a disjunction of the ependymal cilia is present [40]. The neural tube defects in our study were 33 (29.4%), with the most common being spina bifida, followed by myelomeningocele, encephalocele, and meningocele.


9. Conclusion

Congenital hydrocephalus with a lethal outcome is the result of a significant number of risk factors and is often associated with other malformations. Therefore, it is important to perform a prenatal ultrasound study in pregnancies with risk factors to diagnose possible CH or other malformations. Currently, the prenatal ultrasound is able to visualize ventriculomegaly and should be directed toward the search of other associated malformations, and when they are suspected, an MRI study and genetic testing must follow. In cases of medical abortion, stillbirth, or neonatal death, a fetopathological study must be carried out which enriches our knowledge of malformations, complements and completes the ultrasound examination, modifies genetic counseling, and determines the behavior to be followed when taking responsibility for a subsequent pregnancy. It is also important to further study the associated risk factors and the fetopathological changes in CH in order to increase the success of the ultrasound prenatal diagnosis.


  1. 1. Schechtman KB, Gray DL, Baty JD, Rothman SM. Decision-making for termination of pregnancies with fetal anomalies: Analysis of 53 000 pregnancies. Obstetrics and Gynecology. 2002;99:216-222.
  2. 2. Benute GRG, Nomura RMY, Liao AW, et al. Feelings of women regarding end-of-life decision making after ultrasound diagnosis of a lethal fetal malformation. Midwifery. 2012;28:472-475. DOI: 10.1016/j.midw.2011.06.011
  3. 3. Jeng S, Gupta N, Wrensch M, et al. Prevalence of congenital hydrocephalus in California, 1991-2000. Pediatric Neurology. 2011;45;67-71. DOI: 10.1016/j.pediatrneurol.2011.03.009
  4. 4. Van Landingham M, Nguyen TV, Roberts A, et al. Risk factors of congenital hydrocephalus: A 10 year retrospective study. Journal of Neurology, Neurosurgery, and Psychiatry. 2009;80:213-217. DOI: 10.1136/jnnp.2008.148932
  5. 5. Weller S, Gartner J. Genetic and clinical aspects of X-linked hydrocephalus (L1disease): Mutations in the L1CAM gene. Human Mutation. 2001;18:1-12. DOI: 10.1002/humu.1144
  6. 6. Sípek A, Gregor V, Horácek J, Masátová D. Congenital hydrocephalus 1961-2000. Incidence, prenatal diagnosis and prevalence based on maternal age. Ceská Gynekologie. 2002;67:360-364
  7. 7. Bearer CF. L1 cell adhesion molecule signal cascades: Targets for ethanol developmental neurotoxicity. Neurotoxicology. 2001;22:625-633.
  8. 8. Aolad HM, Inouye M, Hayasaka S, et al. Congenital hydrocephalus caused by exposure to low level X-radiation at early gestational stage in mice. Biological Sciences in Space. 1998;12:256-257
  9. 9. Adeloye A, Warkany J. Experimental congenital hydrocephalus. A review withspecial consideration of hydrocephalus produced by zinc deficiency. Child's Brain. 1976;2:325-360. DOI: 10.1159/000119630
  10. 10. Kazy Z, Puho E, Czeizel AE. Teratogenic potential of vaginal metronidazole treatment during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2005;123:174-178. DOI: 10.1016/j.ejogrb.2005.03.016
  11. 11. Fernell E, Hagberg C, von Wendt L.Epidemiology of infantile hydrocephalus in Sweden II. Origin in infants born at term.Acta paediatrica Scandinavica 1987;76:411-417. DOI: 10.1111/j.1651-2227.1987.tb10491.x
  12. 12. Stoll C, Alembik Y, Dott B, Roth MP. Epidemiologic study of environmental and genetic factors in congenital hydrocephalus. European Journal of Epidemiology. 1992;8(6):797-803. Available from:
  13. 13. Porto R, Reis FP, Oliveira C, et al. Prevalence and factors associated at presence of central nervous system congenital malformations. British Journal of Medicine & Medical Research. 2015;6(10):956-964. DOI: 10.9734/BJMMR/2015/14642
  14. 14. Rittler M, Liascovich R, López Camalo J, Castilla J. Parental consanguinity in specifics types of congenital anomalies. American Journal of Medical Genetics. 2001;102:36-43. DOI: 10.1002/1096-8628(20010722)102:1<36::AID-AJMG1394>3.0.CO;2-M
  15. 15. Fernell E, Hagberg B, Hagberg G, von Wendt L. Epidemiology of infantile hydrocephalus in Sweden. III. Origin in preterm infants. Acta Paediatrica Scandinavica. 1987;76:418-423. DOI: 10.1111/j.1651-2227.1987.tb10492.x
  16. 16. Kitova T, Kitov B, Milkov D, Cheih N, Gaigi S. Fetal hydrocephalus. Pteridines. 2014;25(3-4):65-68. DOI: 10.1515/pterid-2014-0007
  17. 17. Munch TN, Rostgaard K, Rasmussen M-L H, et al. Familial aggregation of congenital hydrocephalusin a nation wide cohort. Brain. 2012:135;2409-2415. DOI: 10.1093/brain/aws158. Epub 2012 Jul 4
  18. 18. Garne E, Loane M, Addor MC, et al. Congenital hydrocephalus – Prevalence, prenatal diagnosis and outcome of pregnancy in four European regions. European Journal of Paediatric Neurology. 2010;14:150-155. DOI: 10.1016/j.ejpn.2009.03.005 Epub May 2, 2009
  19. 19. Yang J, Cummings EA, O’Connell C, et al. Fetal and neonatal outcomes of diabetic pregnancies. Obstetrics and Gynecology. 2006;108:644-650. DOI: 10.1097/01.AOG.0000231688.08263.47
  20. 20. Macintosh MC, Fleming KM, Bailey JA, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: Population based study. British Medical Journal. 2006;333(177):1-6. DOI: 10.1136/bmj.38856.692986.AE
  21. 21. Verhagen JM, Schrander-Stumpel CT, Krapels IP, et al. Congenital hydrocephalus in clinical practice: A genetic diagnostic approach. European Journal of Medical Genetics. 2011;54:e542-e547. DOI: 10.1016/j.ejmg.2011.06.005 Epub 2011 Jul 30
  22. 22. Snijders RJM, Nicolaides KH. Fetal biometry at 14-40 weeks’gestation. Ultrasound in Obstetrics & Gynecology. 1994;4:34-48. DOI: 10.1046/j.1469-0705.1994.04010034.x
  23. 23. Tully HM, DobynsWB. Infantile hydrocephalus: A review of epidemiology, classification and causes. European Journal of Medical Genetics. August 2014;57(8):359-368. DOI: 10.1016/j.ejmg.2014.06.002. Epub Jun 13, 2014
  24. 24. Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. American Journal of Medical Genetics. 1989;32(2):195-210. DOI: 10.1002/ajmg.1320320213
  25. 25. Miller G, Ladda RL, Towfighi J. Cerebro-ocular dysplasia-muscular dystrophy (Walker Warburg) syndrome. Findings in 20-week-old fetus. Acta Neuropathologica. 1991;82(3):234-238. DOI: 10.1007/BF00294451
  26. 26. Longman C, Mercuri E, Cowan F, et al. Antenatal and postnatal brain magnetic resonance imaging in muscle-eye- brain disease. Archives of Neurology. 2004;61(8):1301-1306. DOI: 10.1001/archneur.61.8.1301
  27. 27. Plawner LL, Delgado MR,Miller VS, et al. Neuroanatomy of holoprosencephaly as predictor of function Beyond the face predicting the brain.Neurology 2002; 59(7):1058-1066. DOI:
  28. 28. Ishak GE, Dempsey JC, Shaw DWW, et al. Rhombencephalosynapsis: A hindbrain malformation associated with incomplete separation of midbrain and forebrain, hydrocephalus and a broad spectrum of severity. Brain. 2012;135(Pt 5):1370-1386. DOI: 10.1093/brain/aws065 Epub Mar 26, 2012
  29. 29. Spennato P, La Porta A, Varone A, et al. Aicardi and Turner syndrome in a 45,X0/46,XX female. Clinical Neurology and Neurosurgery 2013;115(6):820-822. DOI: 10.1016/j.clineuro.2012.07.030. Epub 2012 Aug 13
  30. 30. Paul LK, Brown WS, Adolphs R, et al. Agenesis of the corpus callosum: Genetic, developmental and functional aspects of connectivity. Nature Reviews. Neuroscience. 2007;8(4):287-299. DOI: 10.1038/NRN2107
  31. 31. Kato M, Das S, Petras K, et al. Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation. Human Mutation 2004; 23(2):147-159.DOI:10.1002/humu.10310
  32. 32. Schrander Stumpel C, Fryns JP. Congenital hydrocephalus: Nosology and guidelines for clinical approach and genetic counselling. European Journal of Pediatrics. 1998;157(5):355-362.
  33. 33. McLone DG, Knepper PA. The cause of Chiari II malformation: A unified theory: A unified theory. Pediatric Neuroscience. 1989;15(1):1-12. DOI: 10.1159/000120432
  34. 34. Sweeney KJ et al. Spinal level of myelomeningocele lesion as a contributing factor in posterior fossa volume, intracranial cerebellar volume, and cerebellar ectopia. Journal of Neurosurgery. Pediatrics. 2013;11(2):154-159.
  35. 35. Seo JH, ZilberY, Babayeva S, et al. Mutations in the planar cell polarity gene, fuzzy, are associated with neural tube defects in humans. Human Molecular Genetics 2011; 20(22):4324-4333. DOI: 10.1093/hmg/ddr359. Epub Aug 12, 2011
  36. 36. Bartsch O, Kirmes I, Thiede A, et al. Novel VANGL1 gene mutations in 144 Slovakian, Romanian and German patients with neural tube defects. Molecular Syndromology. 2012;3(2):76-81. DOI: 10.1159/000339668 Epub Jul 5, 2012
  37. 37. Allacher R, De Marco P, Merello E, et al. Role of the planar cell polarity gene CELSR1 in neural tube defects and caudal agenesis. Birth Defects Research. Part A, Clinical and Molecular Teratology. 2012;94(3):176-181. DOI: 10.1002/bdra.23002 Epub Feb 28, 2012
  38. 38. Tissir F, Qu Y, Montcouquiol M, et al. Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus. Nature Neuroscience. 2010;13(6):700-707. DOI: 10.1038/nn.2555 Epub May 16, 2010
  39. 39. Al-Dosari MS, Mohammed Al-Owain M, Tulbah M, et al. Mutation in MPDZ causes severe congenital hydrocephalus. Journal of Medical Genetics. 2013;50(1):54-58. DOI: 10.1136/jmedgenet-2012-101294
  40. 40. Sotak BN, Gleeson JG. Can't get there from here: Cilia and hydrocephalus. Nature Medicine. 2012;18(12):1742-1743. DOI: 10.1038/nm.3011

Written By

Tanya Kitova, Borislav Kitov, Denis Milkov and Aida Masmoudi

Submitted: 23 May 2017 Reviewed: 25 October 2017 Published: 20 December 2017